Clinical effect of introduction of sevelamer hydrochloride in patients with hyperphosphatemia undergoing maintenance dialysis
Tahara, H.; Tsujimoto, Y.; Shouji, T.; Inaba, M.; Tabata, T.; Nishizawa, Y.
Clinical Calcium 15(Suppl 1): 173-179
2005
ISSN/ISBN: 0917-5857 PMID: 16279021 Document Number: 592025
Document emailed within 1 workday
Related Documents
Chertow, G.M.; Dillon, M.; Burke, S.K.; Steg, M.; Bleyer, A.J.; Garrett, B.N.; Domoto, D.T.; Wilkes, B.M.; Wombolt, D.G.; Slatopolsky, E. 1999: A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients Clinical Nephrology 51(1): 18-26Tomori, K.; Nakamoto, H.; Kotaki, S.; Ishida, Y.; Takane, H.; Nemoto, H.; Kanno, Y.; Sugahara, S.; Okada, H.; Suzuki, H. 2003: Gastric angiodysplasia in patients undergoing maintenance dialysis Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 19: 136-142
Murasawa, T.; Sakai, Y.; Sakai, S.; Ohtsuka, T.; Ohno, D.; Amitani, K-ichi.; Ono, T.; Munakata, K. 2008: QT dispersion increases during hemodialysis procedures in patients undergoing maintenance dialysis: association with an RA system and holter electrocardiogram Nihon Jinzo Gakkai Shi 50(4): 481-487
Kanatu, K. 1977: Clinical studies of hypertension in patients undergoing regular maintenance hemodialysis. 1) a comparison of hemodynamic data and plasma renin activity between responsive and resistant hypertension to regular dialysis alone. 2) Beta adrenergic blockade in resistant hypertension Nihon Jinzo Gakkai Shi 19(11): 871-881
Séchet, A.; Abighanem, O.; Said, S.; Rasombololona, M.; Morinière, P.; Brazier, M.; Fournier, A. 1999: Role of the time of administration of calcium carbonate (before or during mealtime) in the control of hyperphosphatemia in patients on maintenance hemodialysis Nephrologie 20(4): 209-212
Nand, N.; Giri, K.; Jain, D. 2019: Role of Ferric Citrate in Hyperphosphatemia and Iron Deficiency Anemia in Non Dialysis CKD Patients Journal of the Association of Physicians of India 67(4): 53-56
Atkins, R.C.; Holdsworth, S.R.; Fitzgerald, M.G.; Hosking, C.S. 1978: The effect of maintenance dialysis on lymphocyte function. II. Peritoneal dialysis Clinical and Experimental Immunology 33(1): 102-106
Senatore, M.; Coppolino, G.; Papalia, T.; Greco, R.; Lofaro, D.; Bonofiglio, R. 2011: Does concomitant administration of sevelamer hydrochloride and lanthanum carbonate modify the control of phosphatemia? European Review for Medical and Pharmacological Sciences 15(11): 1352-1354
Ortiz, A.; Ríos, F.; Melero, R.; Reyero, A.; Gazapo, R.; Casado, S. 2003: Experience with sevelamer in peritoneal dialysis Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 23(5): 432-436
Rubin, J.; Case, G.; Bower, J. 1990: Comparison of rehabilitation in patients undergoing home dialysis. Continuous ambulatory or cyclic peritoneal dialysis vs home hemodialysis Archives of Internal Medicine 150(7): 1429-1431
Fourtounas, C.; Savidaki, E.; Roumelioti, M.; Dousdampanis, P.; Hardalias, A.; Kalliakmani, P.; Papachristou, E.; Drakopoulos, A.; Goumenos, D.S.; Vlachojannis, J.G. 2006: Acid-base profile and predictors of metabolic acidosis in patients undergoing peritoneal dialysis with lactate- and bicarbonate-buffered peritoneal dialysis solutions Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 22: 187-191
Holdsworth, S.R.; Fitzgerald, M.G.; Hosking, C.S.; Atkins, R.C. 1978: The effect of maintenance dialysis on lymphocyte function. I. Haemodialysis Clinical and Experimental Immunology 33(1): 95-101
Hoenich, N.A. 2003: Effect of dialysis dose and membrane flux in maintenance hemodialysis New England Journal of Medicine 348(15): 1491-1494; Author Reply 1491-1494
Troskot, B.; Kes, P.; Duvnjak, M.; Ratković-Gusić, I.; Supanc, V. 1995: Giant peptic ulcers in patients undergoing maintenance hemodialysis Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 49(2): 59-64
Zhang, D.-l.; Wang, Z.-g. 2003: Study on the mortality-related factors in patients undergoing maintenance hemodialysis Zhonghua Liu Xing Bing Xue Za Zhi 24(6): 508-511
Ing, T.S.; Mahurkar, S.D.; Dunea, G.; Hayashi, J.A.; Klawans, H.L.; Markey, W.S. 1976: Removal of amantadine hydrochloride by dialysis in patients with renal insufficiency Canadian Medical Association Journal 115(6): 515
Ando, R. 2014: Perioperative nutrition management in maintenance dialysis patients Nihon Geka Gakkai Zasshi 115(6): 338-342
Laroussinie, G.; Levesque, C.; Rouby, J.J.; Rottembourg, J.; Chigot, J.P. 1981: Surgery in patients with chronic renal failure on maintenance dialysis La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 57(45-46): 1905-1910
Katus, H.A.; Haller, C.; Müller-Bardorff, M.; Scheffold, T.; Remppis, A. 1995: Cardiac troponin T in end-stage renal disease patients undergoing chronic maintenance hemodialysis Clinical Chemistry 41(8 Part 1): 1201-1203
Feinfeld, D.A.; Kaplan, R.; Dressler, R.; Lynn, R.I. 1989: Survival of human immunodeficiency virus-infected patients on maintenance dialysis Clinical Nephrology 32(5): 221-224